Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PeptiDream
Biotech
Novartis pays PeptiDream $180M as radiopharma big bang continues
Novartis is handing $180 million to serial dealmaker PeptiDream to expand a peptide-drug conjugate collaboration.
Nick Paul Taylor
Apr 30, 2024 4:12am
Genentech signs off on $1B biobucks to expand PeptiDream collab
Sep 20, 2023 7:14am
Astellas pays PeptiDream $21M in latest protein degrader pact
Jul 25, 2023 9:29am
Novo-backed Amolyt Pharma snags $80M for endocrine pipeline
Sep 16, 2021 10:15am
PeptiDream signs licensing deal with Alnylam worth up to $2.2B
Jul 30, 2021 10:05am
Takeda's CNS deep dive with PeptiDream could net $3.5B
Jul 28, 2021 10:41am
